+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

TeraWulf Inc (WULF) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • July 2026
  • GlobalData
  • ID: 5749108
TeraWulf Inc (WULF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TeraWulf Inc (TeraWulf) is digital asset technology service provider company. It is involved in bitcoin mining business. The company develops, own and operates bitcoin mining facility sites in the US, including Lake Mariner, and Nautilus Cryptomine. The Lake Mariner facility is located on the shores of Lake Ontario, Lake Mariner Mining. It is a hydro-powered mining facility for energy transition and secured 90 MW of priced power in Western New York. The Nautilus Cryptomine facility is located in the PJM interconnection and is a partnership between TeraWulf’s nuclear mining facility subsidiary and Talen Energy. Nautilus benefits from zero carbon power supply directly from the nuclear facility. It has presence across states in the US. TeraWulf is headquartered in Duluth, Minnesota, the US.

TeraWulf Inc Key Recent Developments

  • May 26, 2026: Schneider Electric Progresses Phased Delivery of Over $290M in AI Infrastructure Solutions, Including Motivair Technologies, at TeraWulf's Google-Backed Lake Mariner Campus
  • May 08, 2026: TeraWulf Reports First Quarter 2026 Results
  • Mar 24, 2026: Terawulf CEO On Pivot From Crypto Mining to AI Data Center Supplier
  • Feb 26, 2026: TeraWulf Reports Fourth Quarter and Full Year 2025 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Moderna Inc - Key Facts
  • Moderna Inc - Key Employees
  • Moderna Inc - Key Employee Biographies
  • Moderna Inc - Major Products and Services
  • Moderna Inc - History
  • Moderna Inc - Company Statement
  • Moderna Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Moderna Inc - Business Description
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Moderna Inc - Corporate Strategy
  • Moderna Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Moderna Inc - Strengths
  • Moderna Inc - Weaknesses
  • Moderna Inc - Opportunities
  • Moderna Inc - Threats
  • Moderna Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Moderna Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 08, 2026: Moderna Appoints Michael McDonnell to Board of Directors
  • Jun 26, 2026: Moderna highlights expanding mRNA platform at Science Day
  • Jun 18, 2026: Moderna: FDA Advisory Committee Votes Unanimously That Benefits of mRNA-1010 Outweigh Risks
  • Jun 17, 2026: Moderna to Host Investor Event - Science Day
  • Jun 16, 2026: Moderna Announces Ester Banque as Chief Commercial Officer
  • Jun 16, 2026: Moderna Reorganizes to Prepare for Product Launches in 2027 and 2028
  • Jun 15, 2026: mRNA Flu Vaccine Offers Immune Protection Against Wide Array of Influenza Virus Strains
  • Jun 01, 2026: ASCO26: Cancer vaccines and at-home injectable drugs continue to show promise
  • May 15, 2026: Biologics Market Momentum Accelerates Across Healthcare, AI, and Global Medical Tourism
  • May 12, 2026: Moderna Recognized by TIME as One of the World's Most Impactful Companies
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Moderna Inc, Key Facts
  • Moderna Inc, Key Employees
  • Moderna Inc, Key Employee Biographies
  • Moderna Inc, Major Products and Services
  • Moderna Inc, History
  • Moderna Inc, Subsidiaries
  • Moderna Inc, Key Competitors
  • Moderna Inc, Ratios based on current share price
  • Moderna Inc, Annual Ratios
  • Moderna Inc, Interim Ratios
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Moderna Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Moderna Inc, Performance Chart (2021 - 2025)
  • Moderna Inc, Ratio Charts
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Moderna Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026